Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

Results of the highly anticipated Best Oral Presentation and Best Poster Awards were announced at SingHealth Duke-NUS Scientific Congress 2012, held on 3 and 4 August 2012 at the Raffles City Convention Centre.

The SingHealth Duke-NUS Scientific Congress abstract awards recognise research excellence in basic, translational, clinical, evidence-based and health services and systems research. They encourage healthcare professionals from students and doctors to nurses and allied health professionals to pursue ideas and innovations that improve patient care.

This year, more than 500 submissions were whittled down to just 36 awards in 10 categories. The winning abstracts included a breakthrough treatment to combat post-surgical scarring in glaucoma patients, potential new biomarkers to help identify pregnant women at risk of pre-eclampsia and a study that looked at the impact of virtual reality rehabilitation as an adjunct to conventional therapy for people with sub-acute stroke.

"The SingHealth Duke-NUS joint Scientific Congress is an important platform for sharing ideas, innovations and discoveries as we come together to shape the future of medicine," said Professor Ivy Ng, Group Chief Executive Officer, SingHealth. "I congratulate all the winners on their fine work."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare